Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
167.97 4.60(2.82%) Jul 22, 3:59PM EDT
Prev Close:163.37
Open:164.26
Bid:120.00 x 200
Ask:183.36 x 100
1y Target Est:193.89
Beta:0.51
Next Earnings Date:24-Jul-14ALXN Earnings announcement
Day's Range:164.26 - 168.41
52wk Range:100.89 - 185.43
Volume:1,588,628
Avg Vol (3m):1,248,590
Market Cap:33.22B
P/E (ttm):101.55
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 2.82%33.22B
AMGN91.68B
BAX41.71B

Key Statistics

Forward P/E (1 yr):30.05
P/S (ttm):18.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :4.86
Quarterly EPS Est (Jun-14) :1.07
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback